Esperion Therapeutics, Inc. ( ESPR) - Key Metrics
Stock symbol ESPR is outdated, potentially delisted? Maybe it is available on other exchange?
ESPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0.32 | -$0.10 | -$0.11 | -$0.11 |
| 2025Q4 | $0.71 | $0.26 | $0.19 | $0.19 |
| 2025Q3 | $0.44 | -$0.16 | -$0.02 | -$0.02 |
| 2025Q2 | $0.42 | -$0.06 | -$0.16 | -$0.16 |
| 2025Q1 | $0.33 | -$0.21 | -$0.12 | -$0.12 |
ESPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -6.85 |
| 2025Q4 | 0% | 3.56 |
| 2025Q3 | 0% | -4.14 |
| 2025Q2 | 0% | -10.17 |
| 2025Q1 | 0% | -1.71 |
ESPR
Price: $3.18
52 week price:
Earnings Per Share: -0.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 623424
Ebitda: -37.8 millionMarket Capitalization: 661.1 million